The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Gilenya is an immunomodulating drug, mostly used for treating multiple sclerosis (MS). Fingolimod is a sphingosine-1-phosphate receptor modulator, which sequesters lymphocytes in lymph nodes, preventing them from contributing to an autoimmune reaction.
The global Gilenya market was valued at US$ 2013 million in 2023 and is anticipated to reach US$ 934.9 million by 2030, witnessing a CAGR of -8.7% during the forecast period 2024-2030.
The Gilenya market is primarily driven by the growing demand for effective treatments for multiple sclerosis (MS), particularly relapsing forms of the disease. Gilenya (fingolimod) is an oral medication that modulates immune system responses, aiming to reduce relapses and slow down disease progression. The increasing prevalence of MS and the need for therapies that offer convenience and improved quality of life contribute to market growth. Moreover, the shift from injectable to oral treatments and the potential to decrease relapse rates further propel adoption. However, challenges include potential cardiac effects during the initial dose and the need for monitoring patients for safety. Navigating the competitive landscape of MS treatments and addressing affordability and access barriers for a wider patient population are ongoing concerns. The market's success hinges on continuous research to enhance safety profiles, comprehensive patient education about potential benefits and risks, and collaborations between pharmaceutical companies, healthcare providers, and MS patient organizations to optimize MS management while addressing the evolving challenges associated with Gilenya therapy.
This report aims to provide a comprehensive presentation of the global market for Gilenya, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gilenya.
Report Scope
The Gilenya market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Gilenya market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gilenya manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis
Segment by Type
28 Capsules/Box
96 Capsules/Box
Segment by Application
Retail Pharmacy
Hospital Pharmacy
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Gilenya manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Gilenya in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Gilenya is an immunomodulating drug, mostly used for treating multiple sclerosis (MS). Fingolimod is a sphingosine-1-phosphate receptor modulator, which sequesters lymphocytes in lymph nodes, preventing them from contributing to an autoimmune reaction.
The global Gilenya market was valued at US$ 2013 million in 2023 and is anticipated to reach US$ 934.9 million by 2030, witnessing a CAGR of -8.7% during the forecast period 2024-2030.
The Gilenya market is primarily driven by the growing demand for effective treatments for multiple sclerosis (MS), particularly relapsing forms of the disease. Gilenya (fingolimod) is an oral medication that modulates immune system responses, aiming to reduce relapses and slow down disease progression. The increasing prevalence of MS and the need for therapies that offer convenience and improved quality of life contribute to market growth. Moreover, the shift from injectable to oral treatments and the potential to decrease relapse rates further propel adoption. However, challenges include potential cardiac effects during the initial dose and the need for monitoring patients for safety. Navigating the competitive landscape of MS treatments and addressing affordability and access barriers for a wider patient population are ongoing concerns. The market's success hinges on continuous research to enhance safety profiles, comprehensive patient education about potential benefits and risks, and collaborations between pharmaceutical companies, healthcare providers, and MS patient organizations to optimize MS management while addressing the evolving challenges associated with Gilenya therapy.
This report aims to provide a comprehensive presentation of the global market for Gilenya, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gilenya.
Report Scope
The Gilenya market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Gilenya market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gilenya manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis
Segment by Type
28 Capsules/Box
96 Capsules/Box
Segment by Application
Retail Pharmacy
Hospital Pharmacy
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Gilenya manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Gilenya in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Gilenya Market Overview
1.1 Product Overview and Scope of Gilenya
1.2 Gilenya Segment by Type
1.2.1 Global Gilenya Market Value Comparison by Type (2024-2030)
1.2.2 28 Capsules/Box
1.2.3 96 Capsules/Box
1.3 Gilenya Segment by Application
1.3.1 Global Gilenya Market Value by Application: (2024-2030)
1.3.2 Retail Pharmacy
1.3.3 Hospital Pharmacy
1.3.4 Other
1.4 Global Gilenya Market Size Estimates and Forecasts
1.4.1 Global Gilenya Revenue 2019-2030
1.4.2 Global Gilenya Sales 2019-2030
1.4.3 Global Gilenya Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Gilenya Market Competition by Manufacturers
2.1 Global Gilenya Sales Market Share by Manufacturers (2019-2024)
2.2 Global Gilenya Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Gilenya Average Price by Manufacturers (2019-2024)
2.4 Global Gilenya Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Gilenya, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Gilenya, Product Type & Application
2.7 Gilenya Market Competitive Situation and Trends
2.7.1 Gilenya Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Gilenya Players Market Share by Revenue
2.7.3 Global Gilenya Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Gilenya Retrospective Market Scenario by Region
3.1 Global Gilenya Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Gilenya Global Gilenya Sales by Region: 2019-2030
3.2.1 Global Gilenya Sales by Region: 2019-2024
3.2.2 Global Gilenya Sales by Region: 2025-2030
3.3 Global Gilenya Global Gilenya Revenue by Region: 2019-2030
3.3.1 Global Gilenya Revenue by Region: 2019-2024
3.3.2 Global Gilenya Revenue by Region: 2025-2030
3.4 North America Gilenya Market Facts & Figures by Country
3.4.1 North America Gilenya Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Gilenya Sales by Country (2019-2030)
3.4.3 North America Gilenya Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Gilenya Market Facts & Figures by Country
3.5.1 Europe Gilenya Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Gilenya Sales by Country (2019-2030)
3.5.3 Europe Gilenya Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Gilenya Market Facts & Figures by Country
3.6.1 Asia Pacific Gilenya Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Gilenya Sales by Country (2019-2030)
3.6.3 Asia Pacific Gilenya Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Gilenya Market Facts & Figures by Country
3.7.1 Latin America Gilenya Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Gilenya Sales by Country (2019-2030)
3.7.3 Latin America Gilenya Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Gilenya Market Facts & Figures by Country
3.8.1 Middle East and Africa Gilenya Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Gilenya Sales by Country (2019-2030)
3.8.3 Middle East and Africa Gilenya Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Gilenya Sales by Type (2019-2030)
4.1.1 Global Gilenya Sales by Type (2019-2024)
4.1.2 Global Gilenya Sales by Type (2025-2030)
4.1.3 Global Gilenya Sales Market Share by Type (2019-2030)
4.2 Global Gilenya Revenue by Type (2019-2030)
4.2.1 Global Gilenya Revenue by Type (2019-2024)
4.2.2 Global Gilenya Revenue by Type (2025-2030)
4.2.3 Global Gilenya Revenue Market Share by Type (2019-2030)
4.3 Global Gilenya Price by Type (2019-2030)
5 Segment by Application
5.1 Global Gilenya Sales by Application (2019-2030)
5.1.1 Global Gilenya Sales by Application (2019-2024)
5.1.2 Global Gilenya Sales by Application (2025-2030)
5.1.3 Global Gilenya Sales Market Share by Application (2019-2030)
5.2 Global Gilenya Revenue by Application (2019-2030)
5.2.1 Global Gilenya Revenue by Application (2019-2024)
5.2.2 Global Gilenya Revenue by Application (2025-2030)
5.2.3 Global Gilenya Revenue Market Share by Application (2019-2030)
5.3 Global Gilenya Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Novartis
6.1.1 Novartis Corporation Information
6.1.2 Novartis Description and Business Overview
6.1.3 Novartis Gilenya Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Novartis Gilenya Product Portfolio
6.1.5 Novartis Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Gilenya Industry Chain Analysis
7.2 Gilenya Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Gilenya Production Mode & Process
7.4 Gilenya Sales and Marketing
7.4.1 Gilenya Sales Channels
7.4.2 Gilenya Distributors
7.5 Gilenya Customers
8 Gilenya Market Dynamics
8.1 Gilenya Industry Trends
8.2 Gilenya Market Drivers
8.3 Gilenya Market Challenges
8.4 Gilenya Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Gilenya Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Gilenya Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Gilenya Market Competitive Situation by Manufacturers in 2023
Table 4. Global Gilenya Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Gilenya Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Gilenya Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Gilenya Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Gilenya Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Gilenya, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Gilenya, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Gilenya, Product Type & Application
Table 12. Global Key Manufacturers of Gilenya, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Gilenya by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gilenya as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Gilenya Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Gilenya Sales by Region (2019-2024) & (K Units)
Table 18. Global Gilenya Sales Market Share by Region (2019-2024)
Table 19. Global Gilenya Sales by Region (2025-2030) & (K Units)
Table 20. Global Gilenya Sales Market Share by Region (2025-2030)
Table 21. Global Gilenya Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Gilenya Revenue Market Share by Region (2019-2024)
Table 23. Global Gilenya Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Gilenya Revenue Market Share by Region (2025-2030)
Table 25. North America Gilenya Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Gilenya Sales by Country (2019-2024) & (K Units)
Table 27. North America Gilenya Sales by Country (2025-2030) & (K Units)
Table 28. North America Gilenya Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Gilenya Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Gilenya Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Gilenya Sales by Country (2019-2024) & (K Units)
Table 32. Europe Gilenya Sales by Country (2025-2030) & (K Units)
Table 33. Europe Gilenya Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Gilenya Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Gilenya Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Gilenya Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Gilenya Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Gilenya Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Gilenya Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Gilenya Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Gilenya Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Gilenya Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Gilenya Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Gilenya Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Gilenya Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Gilenya Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Gilenya Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Gilenya Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Gilenya Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Gilenya Sales (K Units) by Type (2019-2024)
Table 51. Global Gilenya Sales (K Units) by Type (2025-2030)
Table 52. Global Gilenya Sales Market Share by Type (2019-2024)
Table 53. Global Gilenya Sales Market Share by Type (2025-2030)
Table 54. Global Gilenya Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Gilenya Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Gilenya Revenue Market Share by Type (2019-2024)
Table 57. Global Gilenya Revenue Market Share by Type (2025-2030)
Table 58. Global Gilenya Price (US$/Unit) by Type (2019-2024)
Table 59. Global Gilenya Price (US$/Unit) by Type (2025-2030)
Table 60. Global Gilenya Sales (K Units) by Application (2019-2024)
Table 61. Global Gilenya Sales (K Units) by Application (2025-2030)
Table 62. Global Gilenya Sales Market Share by Application (2019-2024)
Table 63. Global Gilenya Sales Market Share by Application (2025-2030)
Table 64. Global Gilenya Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Gilenya Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Gilenya Revenue Market Share by Application (2019-2024)
Table 67. Global Gilenya Revenue Market Share by Application (2025-2030)
Table 68. Global Gilenya Price (US$/Unit) by Application (2019-2024)
Table 69. Global Gilenya Price (US$/Unit) by Application (2025-2030)
Table 70. Novartis Corporation Information
Table 71. Novartis Description and Business Overview
Table 72. Novartis Gilenya Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Novartis Gilenya Product
Table 74. Novartis Recent Developments/Updates
Table 75. Key Raw Materials Lists
Table 76. Raw Materials Key Suppliers Lists
Table 77. Gilenya Distributors List
Table 78. Gilenya Customers List
Table 79. Gilenya Market Trends
Table 80. Gilenya Market Drivers
Table 81. Gilenya Market Challenges
Table 82. Gilenya Market Restraints
Table 83. Research Programs/Design for This Report
Table 84. Key Data Information from Secondary Sources
Table 85. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Gilenya
Figure 2. Global Gilenya Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Gilenya Market Share by Type in 2023 & 2030
Figure 4. 28 Capsules/Box Product Picture
Figure 5. 96 Capsules/Box Product Picture
Figure 6. Global Gilenya Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Gilenya Market Share by Application in 2023 & 2030
Figure 8. Retail Pharmacy
Figure 9. Hospital Pharmacy
Figure 10. Other
Figure 11. Global Gilenya Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Gilenya Market Size (2019-2030) & (US$ Million)
Figure 13. Global Gilenya Sales (2019-2030) & (K Units)
Figure 14. Global Gilenya Average Price (US$/Unit) & (2019-2030)
Figure 15. Gilenya Report Years Considered
Figure 16. Gilenya Sales Share by Manufacturers in 2023
Figure 17. Global Gilenya Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Gilenya Players: Market Share by Revenue in 2023
Figure 19. Gilenya Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Gilenya Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Gilenya Sales Market Share by Country (2019-2030)
Figure 22. North America Gilenya Revenue Market Share by Country (2019-2030)
Figure 23. United States Gilenya Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Gilenya Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Gilenya Sales Market Share by Country (2019-2030)
Figure 26. Europe Gilenya Revenue Market Share by Country (2019-2030)
Figure 27. Germany Gilenya Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Gilenya Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Gilenya Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Gilenya Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Gilenya Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Gilenya Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Gilenya Revenue Market Share by Region (2019-2030)
Figure 34. China Gilenya Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Gilenya Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Gilenya Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Gilenya Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Gilenya Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. China Taiwan Gilenya Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Gilenya Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Gilenya Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Gilenya Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Gilenya Sales Market Share by Country (2019-2030)
Figure 44. Latin America Gilenya Revenue Market Share by Country (2019-2030)
Figure 45. Mexico Gilenya Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Gilenya Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Gilenya Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Gilenya Sales Market Share by Country (2019-2030)
Figure 49. Middle East & Africa Gilenya Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Gilenya Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Gilenya Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. UAE Gilenya Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Gilenya by Type (2019-2030)
Figure 54. Global Revenue Market Share of Gilenya by Type (2019-2030)
Figure 55. Global Gilenya Price (US$/Unit) by Type (2019-2030)
Figure 56. Global Sales Market Share of Gilenya by Application (2019-2030)
Figure 57. Global Revenue Market Share of Gilenya by Application (2019-2030)
Figure 58. Global Gilenya Price (US$/Unit) by Application (2019-2030)
Figure 59. Gilenya Value Chain
Figure 60. Gilenya Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
